Efeitos do tratamento não cirúrgico da periodontite crônica sobre marcadores inflamatórios em pacientes com doença renal crônica
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora
DOI
Abstract
This is an interventional controlled clinical assay. The aim of this study was to
determine the impact of periodontal treatment (PT) on the systemic markers of
inflammation and to determine a correlation betwen serum level of prohepcidin
(prohormone of hepcidin) and chronic periodontitis (CP) in patients with chronic
kidney disease (CKD) who were not yet under dialysis. This study included 56
patients with CP moderate to severe, 36 with CKD (CKD group) and 20 without
systemic diseases and with normal renal function (control group). CKD was defined
as suggested by the K/DOQI of National Kidney Foundation. CP was defined by the
clinical attachment level (CAL) and the probing pocket depth (PPD), according to the
American Association of Periodontology (AAP). The participants received no surgical
periodontal treatment and inflammatory markers ultrasensitive C-reactive protein (us-
PCR), interleukin-6 (IL-6), and prohepcidin were evaluated before and 3 months after
PT. The results proven effective PT was by measuring decreases in CAL and PPD
following PT in the control (2,37±0,40 vs. 2,02± 0,43, p <0,05 and 2,52±0,41 vs.
1,98± 0,40, p <0,05), and CKD groups (2,92±0,92 vs. 2,20± 0,65, p <0,05 and
2,90±1,13 vs. 1,99± 0,82, p <0,05). PT resulted in a statistically significant reduction
in us-PCR and IL-6 levels in both groups. Additionally, there was a significant fall in
serum prohepcidin (ng/mL) after PT in the control group (147.39±5150 vs.
131.72±47.10, p<0.01) and CKD group (166.24±55.70 vs. 153.29±56.90, p<0.05).
Moreover, in multivariated linear regression, the reduction of prohepcidin levels after
PT was significantly and independently associated with IL-6 levels (p=0.02) in the
control group. However, in conclusion CP moderate to severe in patients with CKD,
can determine increase in the systemic inflammatory response. Successful PT, by
inducing a decline in the systemic inflammatory burden and a decrease in serum
prohepcidin. This terapy might constitute an important intervention in ameliorating of
the inflammation seen in patients with CKD.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
